Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07335055 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study for HSK47388 in Participants With Ulcerative Colitis

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jan 29, 2026 to Feb 3, 2026 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Jan 29, 2026 to Feb 3, 2026
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .
Trial Details
NCT Number NCT07335055
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Collaborators: Haisco-USA Pharmaceuticals, Inc.
Conditions Ulcerative Colitis (UC)
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov